Reply to: "CardioMEMS in HF patients: study confirms benefit in costs and QALYs, but does not measure QALYs"

被引：0
|
作者：
Codina, Pau [1 ,2 ]
Lopez-Segui, Francesc [3 ]
Bayes-Genis, Antoni [1 ,2 ]
机构：
[1] Univ Hosp Germans Trias i Pujol, Heart Failure Clin & Cardiol Serv, Badalona, Spain
[2] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
[3] Univ Vic Cent Univ Catalonia UV UCC, Fac Med, Vic, Spain
来源：
ESC HEART FAILURE | 2024年 / 11卷 / 04期
关键词：
D O I：
10.1002/ehf2.14820
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2475 / 2475
页数：1
相关论文
共 50 条
  • [1] Study of CardioMEMS in heart failure patients: Study confirms benefit in costs and quality-adjusted life years, but does not measure quality-adjusted life years
    Messori, Andrea
    Trippoli, Sabrina
    ESC HEART FAILURE, 2024, 11 (06): : 4437 - 4437
  • [2] MOVING BEYOND QALYS: A COMPOSITE INDICATOR TO MEASURE THE BENEFIT OF HEARING IMPLANTS
    Hoch, A.
    Scandurra, F.
    Kiesewetter, K.
    Dejaco, T.
    Rose-Eichberger, K.
    Mag, Schwarz C.
    Urban, M.
    VALUE IN HEALTH, 2022, 25 (12) : S367 - S367
  • [3] Moving beyond QALYs: A composite indicator to measure the benefit of hearing implants
    Urban, Michael
    Hoch, Annegret
    Scandurra, Francesca Maria
    Kiesewetter, Klaas
    Dejaco, Thomas
    Eichberger, Karin Rose
    Schwarz, Christina
    Schlick, Bettina
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP197 - NP198
  • [4] MEASURING THE BENEFITS OF HEALTH CARE: DALYS AND QALYS - DOES THE CHOICE OF MEASURE MATTER? A CASE STUDY
    Colantonio, L.
    Augustovski, F.
    Galante, J.
    Bardach, A.
    Caporale, J.
    Zarate, V
    Chuang, L. H.
    Kind, P.
    VALUE IN HEALTH, 2011, 14 (07) : A536 - A536
  • [5] USING QALYS VERSUS DALYS TO MEASURE COST-EFFECTIVENESS: DOES IT MATTER?
    Feng, X.
    Ollendorf, D. A.
    Kim, D. D.
    Cohen, J. T.
    Neumann, P. J.
    VALUE IN HEALTH, 2019, 22 : S36 - S36
  • [6] Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
    Augustovski, Federico
    Colantonio, Lisandro D.
    Galante, Julieta
    Bardach, Ariel
    Caporale, Joaquin E.
    Zarate, Victor
    Chuang, Ling Hsiang
    Riviere, Andres Pichon
    Kind, Paul
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2018, 7 (02) : 120 - 136
  • [7] Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?
    Feng, Xue
    Kim, David D.
    Cohen, Joshua T.
    Neumann, Peter J.
    Ollendorf, Daniel A.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (02) : 96 - 103
  • [8] Valuing the Q in QALYs: Does Providing Patients' Ratings Affect Population Values?
    Murphy, Robert P.
    Boyce, Christopher J.
    Dolan, Paul
    Wood, Alex M.
    HEALTH PSYCHOLOGY, 2020, 39 (01) : 37 - 45
  • [9] An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy
    Kontodimopoulos, Nick
    Niakas, Dimitris
    HEALTH POLICY, 2008, 86 (01) : 85 - 96
  • [10] Lifetime Costs and QALYs for POAG patients, early stage versus moderate stage treatment: A Preliminary Discrete Event Simulation cohort study
    Htoon, Hla Myint
    Duc Quang Nguyen
    Mani, Baskaran
    Bayer, Steffen
    Lam, Sean Shao Wei
    Nongpiur, Monisha Esther
    Aung, Tin
    Vithana, Eranga Nishanthie
    Lamoureux, Ecosse Luc
    Matchar, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
12345